<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04173364</url>
  </required_header>
  <id_info>
    <org_study_id>2018_66</org_study_id>
    <secondary_id>2019-001984-62</secondary_id>
    <nct_id>NCT04173364</nct_id>
  </id_info>
  <brief_title>Interscalene Block and Dysfunction Diaphragmatic</brief_title>
  <acronym>NUMEROBIS</acronym>
  <official_title>Interscalene Block and Dysfunction Diaphragmatic: Effect of Low Volume of Ropivacaine 0,1%. A Randomised, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study seeks to show that interscalene injection of a small volume (&lt;8ml) of ropivacaine
      at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to
      low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic
      shoulder surgery with ISB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It's a prospective monocentric randomized controlled clinical trial in 2 parallel groups in
      double blind.

      the study concerns patients undergoing arthroscopic shoulder surgery with ISB. The study
      seeks to show that interscalene injection of a small volume (&lt;8ml) of ropivacaine at a low
      concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low
      volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic
      shoulder surgery with ISB.

      Randomization in one of the two arms:

        -  Experimental group: &lt;8ml ropivacaine 0.1%.

        -  Control group: &lt;8mL of ropivacaine 0.5%.

      Evaluation of diaphragmatic stroke by ultrasound and ventilatory function by spirometry and
      snip test before performing the ISB, then after installation of the ISB.

      Performing the surgical procedure under general anesthesia assessment of postoperative
      analgesia and patient satisfaction during the following 48 hours.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 22, 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the occurrence of hemi-diaphragmatic paresis</measure>
    <time_frame>1h after interscalene block</time_frame>
    <description>Hemi diaphragmatic paresis is evaluated by quantifying the homolateral diaphragmatic stroke at interscalene block (ISB) by ultrasound analysis (measured in centimeter), during slow and deep inspiration. Diaphragmatic hemiparesis is defined as a decrease (at post-ISB time vs. pre-ISB time) of more than 25% of the diaphragmatic stroke during this slow and deep inspiration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the frequency of hemi-diaphragmatic paralysis</measure>
    <time_frame>1h after interscalene block</time_frame>
    <description>Hemi-diaphragmatic paralysis refers to the absence of diaphragmatic movement (or paradoxical movement) in ultrasound during rest ventilation and slow, deep inhalation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare intraoperative analgesia</measure>
    <time_frame>peroperative time</time_frame>
    <description>Total consumption of sufentanil, and Analgesia Nociception Index values (ANI, MetroDoloris, France).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare postoperative analgesia</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Duration of effective analgesia (defined as the period up to the first EVA &gt; 3 (excluding PACU Consumption of morphine in PACU and analgesics within the first 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the ventilatory function (spirometry and snip test).</measure>
    <time_frame>1h after interscalene block</time_frame>
    <description>Presence of a respiratory impairment detected by spirometry (Spiro-USB® device) and presence of a diaphragmatic impairment detected by snip test, (micro-RPM®). Ventilation impairment will be considered present if there is a decrease of at least 25% in vital capacity between the pre and post ISB. Diaphragmatic damage is defined as a decrease of at least 25% in the Snip-test values between the pre and post ISB.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare patient satisfaction</measure>
    <time_frame>24 to 48 hours postoperatively</time_frame>
    <description>Evaluation of patient satisfaction by questionnaire at the patient's bedside or by telephone call within 24h-48h postoperatively. It is assessed on a numerical scale from 0 to 10 (0 being the lowest satisfaction value and 10 the highest value)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the contralateral diaphragmatic stroke</measure>
    <time_frame>1h after interscalene block</time_frame>
    <description>Evaluation of contralateral diaphragmatic compensation (diaphragmatic stroke in ultrasound, comparison of post-ISB time vs. pre-ISB time, expressed in %).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Diaphragmatic Paralysis</condition>
  <arm_group>
    <arm_group_label>Experimental group : ropivacaine 0.1%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interscalene block for arthroscopic shoulder surgery with small volume of low concentration (0.1%) of ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group : ropivacaine 0.5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interscalene block for arthroscopic shoulder surgery with small volume of standard concentration (0.5%) of ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5% Injectable Solution</intervention_name>
    <description>Injectable solution of ropivacaine 0.5%</description>
    <arm_group_label>control group : ropivacaine 0.5%</arm_group_label>
    <other_name>naropeine 0.5%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.1% Injectable Solution</intervention_name>
    <description>Dilution of ropivacaine to the concentration of 0.1%</description>
    <arm_group_label>Experimental group : ropivacaine 0.1%</arm_group_label>
    <other_name>Naropeine 0.1%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  orthopedic surgery compatible with interscalene block

          -  french speaking

          -  Patient who signed consent to participate in the study

        Exclusion Criteria:

          -  Pregnant woman

          -  ASA score &gt; 3

          -  Severe chronic respiratory insufficiency

          -  COPD &gt;3 or 4 of Gold score

          -  coagulation trouble

          -  Allergic to medication involved in the study

          -  Breastfeeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud ALLUIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Roger Salengro, CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 20, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>interscalene block</keyword>
  <keyword>shoulder surgery</keyword>
  <keyword>local anesthesic</keyword>
  <keyword>respiratory function</keyword>
  <keyword>diaphragmatic dysfunction</keyword>
  <keyword>echography</keyword>
  <keyword>locoregional anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Paralysis</mesh_term>
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

